The Mail on Sunday provided commentary on Vyke Communications (VYKE), highlighting the addition of 3,000 new customers a day, and suggesting the use of mobile phones abroad being so expensive was a catalyst. It went on that using the service can be up to 95% cheaper than ordinary calls and that CEO Tommy Jensen has shown his commitment, holding over 3% of the business. Analysts expect 10m customers by 2012 and the piece concluded with a ‘buy’ recommendation. Consequently, the shares were ahead by 5.00p at 88.50p this morning.
Hope of a bid for Oxford BioMedica (OXB) from SanofiAventis lifted the share price, according to The Mail on Sunday, as City sources were confident that a deal was imminent. The article noted that the license between the businesses for TroVax could earn OXB up to £386m, according to some analysts, and that Chief Executive Alan Kingsman was said to be holding out for an offer of above 50p a share, which would still cost Sanofi less than its potential costs under the licensing deal. The positive momentum appeared to spill over into Monday morning, where the price increased by 4.25p to reach 23.00p.
Prices above were taken at 9.38am on Monday, 11 February 2008.
The following companies, in which City Equities customers may have an interest, released announcements to the market this morning. These can be found by entering the relevant company name or ticker code in the search box on this site.
Central China Goldfields (GGG): Nimu Copper Project Update.
DDD Group (DDD): Samsung Embedded 3-DHDTV Chip.
Empyrean Energy (EME): Bondi Prospect Update.
Essentially Group (ESN): Signing of Players.
Feedback (FDBK): Update on CVA.
ReGen Therapeutics (RGT): Colostrinin Study Results.
Synchronica (SYNC): Email to SMS Gateway.
Tanfield (TAN): Holdings in Company.
UniVision Engineering (UVEL): CEPA Certification.
Monday, 11 February – UK Government House Price Figures (December) and UK Producer Price Index (January).
Tuesday, 12 February – UK BRC Retail Sales Monitor (January).
Wednesday, 13 February – UK Labour Market Data.
Thursday, 14 February – Nothing of note.
Friday, 15 February – Nothing of note.
The next Penny Share Review will be posted on Monday, 18 February 2008.
Compiled by Chris Richards.
Penny Shares Online - penny shares research and information service.
There is an extra risk of losing money when shares are bought in some smaller companies including 'Penny Shares'. There is a big difference between the buying price and the selling price of these shares. If they have to be sold immediately, you may get back much less than you paid for them or you may have difficulty in selling them. Past performance is not a reliable indicator of future results. The price may change quickly and it may go down as well as up. You could lose every penny put into a particular share.
The information contained above has been compiled from documented sources which are believed to be reliable but, due to their very nature, are subject to a degree of historical inaccuracy and have not been independently verified and cannot be guaranteed. The pages on this website are provided for information only. City Equities Limited will not accept responsibility for loss incurred by any person or body acting, or refraining from acting, as a result of information and/or opinions given anywhere on this website. Issued by City Equities Limited, Aldermary House, 10-15 Queen Street, London, EC4N 1TY. Registered in England. Registered No. 2742847. Registered Address: Amwell House, 19 Amwell Street, Hoddeson, Herts. EN11 8TS. City Equities Limited is Authorised and regulated by the Financial Services Authority. Registration No. 155051.